Survival Model Established by Combined Serum Tumor Markers in Predicating the Effect of Erlotinib on Patients with Recurrent Non-small Cell Lung Cancer

Survival Model Established by Combined Serum Tumor Markers in Predicating the Effect of Erlotinib on Patients with Recurrent Non-small Cell Lung Cancer

Objective: To investigate the relationship of serum pulmonary surfactant-associated pretein (SP-D), transforming growth factor-α (TGF-α), matrix metalloproteinases-9 (MMP-9), tissue polypeptide specific antigen (TPS) and lung adenocarcinoma-related antigen (KL-6) with the effect and survival of trea...

Full description

Bibliographic Details
Main Authors: Lan Shao, Wei Hong, Yiping Zhang
Format: Article
Language:English
Published: Third Party Medicine International Publishing Group Co. Limited 2013-12-01
Series:Journal of International Translational Medicine
Subjects:
Non-small cell lung cancer
Erlotinib
Serum tumor marker
Prognostic factor
Predicative model
Online Access:http://www.jitm.hk/EN/abstract/abstract89.shtml

Internet

http://www.jitm.hk/EN/abstract/abstract89.shtml

Similar Items